Profile | GDS4284 / 215785_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 20354.6 | 99 |
GSM687648 | Patient 402 control | 12055.9 | 98 |
GSM687653 | Patient 403 control | 17243 | 98 |
GSM687658 | Patient 404 control | 14084.3 | 98 |
GSM687663 | Patient 411 control | 18343.2 | 99 |
GSM687668 | Patient 422 control | 14566.2 | 98 |
GSM687673 | Patient 424 control | 18806.4 | 99 |
GSM687678 | Patient 425 control | 17499 | 99 |
GSM687683 | Patient 427 control | 17675.9 | 99 |
GSM687688 | Patient 428 control | 32907.6 | 99 |
GSM687695 | Patient 441 control | 9663.19 | 97 |
GSM687699 | Patient 443 control | 13868.2 | 98 |
GSM687704 | Patient 444 control | 19918.7 | 99 |
GSM687707 | Patient 448 control | 10589.5 | 97 |
GSM687712 | Patient 449 control | 10688.5 | 97 |
GSM687719 | Patient 450 control | 12694.4 | 98 |
GSM687724 | Patient 451 control | 17734.1 | 98 |
GSM687728 | Patient 452 control | 8131.94 | 96 |
GSM687646 | Patient 401 treated 24h | 14634.4 | 98 |
GSM687649 | Patient 402 treated 24h | 10572.9 | 97 |
GSM687665 | Patient 411 treated 24h | 15775.3 | 98 |
GSM687651 | Patient 402 treated 4 weeks | 13724.8 | 98 |
GSM687667 | Patient 411 treated 4 weeks | 16600.8 | 99 |
GSM687670 | Patient 422 treated 24h | 12481.6 | 98 |
GSM687671 | Patient 422 treated 4 weeks | 14494.3 | 98 |
GSM687654 | Patient 403 treated 24h | 17725.5 | 98 |
GSM687675 | Patient 424 treated 24h | 17666.5 | 99 |
GSM687685 | Patient 427 treated 24h | 23610.2 | 99 |
GSM687656 | Patient 403 treated 4 weeks | 20860.2 | 99 |
GSM687677 | Patient 424 treated 4 weeks | 27197.8 | 99 |
GSM687687 | Patient 427 treated 4 weeks | 22803.5 | 99 |
GSM687692 | Patient 428 treated 4h | 22620.4 | 99 |
GSM687716 | Patient 449 treated 4h | 15376.1 | 98 |
GSM687722 | Patient 450 treated 4h | 10804.1 | 97 |
GSM687680 | Patient 425 treated 24h | 13907.1 | 98 |
GSM687690 | Patient 428 treated 24h | 21874.7 | 99 |
GSM687700 | Patient 443 treated 24h | 10951.8 | 97 |
GSM687705 | Patient 444 treated 24h | 22014.4 | 99 |
GSM687714 | Patient 449 treated 24h | 11296.6 | 97 |
GSM687721 | Patient 450 treated 24h | 9713.31 | 97 |
GSM687682 | Patient 425 treated 4 weeks | 17835.6 | 98 |
GSM687694 | Patient 428 treated 4 weeks | 25956.1 | 99 |
GSM687702 | Patient 443 treated 4 weeks | 15194.7 | 98 |
GSM687718 | Patient 449 treated 4 weeks | 19266.2 | 99 |
GSM687723 | Patient 450 treated 4 weeks | 14179.3 | 98 |
GSM687661 | Patient 404 treated 4h | 12150.9 | 98 |
GSM687710 | Patient 448 treated 4h | 12586 | 98 |
GSM687726 | Patient 451 treated 4h | 14655.9 | 98 |
GSM687730 | Patient 452 treated 4h | 26033.1 | 99 |
GSM687660 | Patient 404 treated 24h | 6228.99 | 95 |
GSM687697 | Patient 441 treated 24h | 7787.71 | 96 |
GSM687709 | Patient 448 treated 24h | 10043.6 | 97 |
GSM687725 | Patient 451 treated 24h | 12242.4 | 98 |
GSM687729 | Patient 452 treated 24h | 8115.66 | 96 |
GSM687727 | Patient 451 treated 4 weeks | 20265.5 | 99 |
GSM687731 | Patient 452 treated 4 weeks | 11038.6 | 98 |